Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Purinergic Signaling and Inflammation
  • Language: en
  • Pages: 97

Purinergic Signaling and Inflammation

None

Emerging Therapeutics for Immune Tolerance
  • Language: en
  • Pages: 327

Emerging Therapeutics for Immune Tolerance

None

Host and Microbe Adaptations in the Evolution of Immunity
  • Language: en
  • Pages: 254

Host and Microbe Adaptations in the Evolution of Immunity

The evolution of metazoans has been accompanied by new interfaces with the microbial environment that include biological barriers and surveillance by specialized cell types. Increasingly complex organisms require increased capacities to confront pathogens, achieved by co-evolution of recognition mechanisms and regulatory pathways. Two distinct but interactive forms of immunity have evolved. Innate immunity, shared by all metazoans, is traditionally viewed as simple and non-specific. Adaptive immunity possesses the capacity to anticipate new infectious challenges and recall previous exposures; the most well-understood example of such a system, exhibited by lymphocytes of vertebrates, is based...

Precision Medicine and Immuno-Mediated Inflammatory Diseases: Latest Progress and Next Challenges
  • Language: en
  • Pages: 175
TLR4-Dependent Homeostasis and Immunopathology: Focus on Cross-talk With Other Signaling Pathways
  • Language: en
  • Pages: 169
The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment
  • Language: en
  • Pages: 299

The Immunology of Sepsis – Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment

We acknowledge the initiation and support of this Research Topic by the International Union of Immunological Societies (IUIS). We hereby state publicly that the IUIS has had no editorial input in articles included in this Research Topic, thus ensuring that all aspects of this Research Topic are evaluated objectively, unbiased by any specific policy or opinion of the IUIS.

M1/M2 Macrophages: The Arginine Fork in the Road to Health and Disease
  • Language: en
  • Pages: 281

M1/M2 Macrophages: The Arginine Fork in the Road to Health and Disease

Macrophages have unique and diverse functions necessary for survival. And, in humans (and other species), they are the most abundant leukocytes in tissues. The Innate functions of macrophages that are best known are their unusual ability to either “Kill” or “Repair”. Since killing is a destructive process and repair is a constructive process, it was stupefying how one cell could exhibit these 2 polar – opposite functions. However, in the late 1980’s, it was shown that macrophages have a unique ability to enzymatically metabolize Arginine to Nitric Oxide (NO, a gaseous non – specific killer molecule) or to Ornithine (a precursor of polyamines and collagen for repair). The dual A...

Women in Cytokines and Soluble Mediators in Immunity
  • Language: en
  • Pages: 848

Women in Cytokines and Soluble Mediators in Immunity

We are delighted to present the inaugural Frontiers in Immunology “Women in Cytokines and Soluble Mediators in Immunity” series of article collections. At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and Science, Technology, Engineering and Mathematics (STEM) research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.

Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses
  • Language: en
  • Pages: 172

Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses

Dr. Quintana is the founder of AnTolRx. The other Topic Editor declares no competing interests.